missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human EGF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
202.00€ - 561.00€
Specifications
Accession Number | P01133 |
---|---|
For Use With (Application) | Bioactivity |
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Gene ID (Entrez) | 1950 |
Molecular Weight (g/mol) | M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
18788816
|
R&D Systems™
236-EG-200 |
200 μg |
202.00€
200µg |
Estimated Shipment: 02-12-2024
Log in to see stock. |
|||||
18330548
|
R&D Systems™
236-EG-01M |
1 mg |
561.00€
1mg |
Estimated Shipment: 27-11-2024
Log in to see stock. |
|||||
Description
Measured in a cell proliferation assay using Balb/3T3 mouse embryonic fibroblast cells. Rubin, J.S. et al. (1991) Proc. Natl. Acad. Sci. USA 88:415. The ED50 for this effect is 20-100 pg/mL.Specifications
P01133 | |
Lyophilized from a 0.2 μm filtered solution in PBS. | |
M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa | |
E. coli-derived human EGF protein Asn971-Arg1023, with an N-terminal Met | |
<0.10 EU / 1 μg of the protein by the LAL method. | |
Unconjugated | |
Reconstitute at 500 μg/mL in sterile PBS. | |
EGF |
Bioactivity | |
1950 | |
EGF | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
EGF | |
Recombinant | |
>97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |